Oregon Public Employees Retirement Fund grew its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 44,296.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,565,960 shares of the medical research company’s stock after purchasing an additional 19,521,889 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Thermo Fisher Scientific were worth $87,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of the business. Andra AP fonden boosted its holdings in Thermo Fisher Scientific by 21.7% during the third quarter. Andra AP fonden now owns 17,400 shares of the medical research company’s stock valued at $4,247,000 after acquiring an additional 3,100 shares during the period. BB&T Corp increased its holdings in shares of Thermo Fisher Scientific by 42.2% during the third quarter. BB&T Corp now owns 5,253 shares of the medical research company’s stock worth $1,282,000 after buying an additional 1,560 shares in the last quarter. Oakbrook Investments LLC acquired a new stake in shares of Thermo Fisher Scientific during the third quarter worth approximately $305,000. Cornerstone Wealth Management LLC increased its holdings in shares of Thermo Fisher Scientific by 4.7% during the third quarter. Cornerstone Wealth Management LLC now owns 69,468 shares of the medical research company’s stock worth $359,000 after buying an additional 3,133 shares in the last quarter. Finally, IFM Investors Pty Ltd increased its holdings in shares of Thermo Fisher Scientific by 16.9% during the third quarter. IFM Investors Pty Ltd now owns 21,174 shares of the medical research company’s stock worth $5,168,000 after buying an additional 3,054 shares in the last quarter. Institutional investors own 91.80% of the company’s stock.

TMO has been the subject of a number of research reports. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Friday, November 30th. Robert W. Baird raised their price objective on shares of Thermo Fisher Scientific from $264.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, January 30th. BTIG Research raised their price objective on shares of Thermo Fisher Scientific to $290.00 and gave the company a “buy” rating in a research note on Thursday, January 31st. Finally, Morgan Stanley raised their price objective on shares of Thermo Fisher Scientific from $254.00 to $260.00 and gave the company an “overweight” rating in a research note on Thursday, October 25th. Three investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $275.70.

In other news, CFO Stephen Williamson sold 9,500 shares of Thermo Fisher Scientific stock in a transaction on Friday, December 7th. The shares were sold at an average price of $241.45, for a total transaction of $2,293,775.00. Following the transaction, the chief financial officer now directly owns 44,124 shares of the company’s stock, valued at $10,653,739.80. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Gregory J. Herrema sold 17,235 shares of Thermo Fisher Scientific stock in a transaction on Thursday, November 29th. The stock was sold at an average price of $247.00, for a total transaction of $4,257,045.00. Following the transaction, the insider now directly owns 26,446 shares in the company, valued at $6,532,162. The disclosure for this sale can be found here. Over the last three months, insiders have sold 27,835 shares of company stock worth $6,827,998. Insiders own 0.49% of the company’s stock.

Shares of NYSE TMO opened at $252.49 on Tuesday. The firm has a market cap of $101.65 billion, a PE ratio of 22.71, a PEG ratio of 1.63 and a beta of 1.14. Thermo Fisher Scientific Inc. has a twelve month low of $199.85 and a twelve month high of $253.91. The company has a current ratio of 1.71, a quick ratio of 1.23 and a debt-to-equity ratio of 0.64.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, January 30th. The medical research company reported $3.25 earnings per share for the quarter, topping analysts’ consensus estimates of $3.19 by $0.06. The company had revenue of $6.51 billion for the quarter, compared to analysts’ expectations of $6.26 billion. Thermo Fisher Scientific had a net margin of 12.06% and a return on equity of 16.86%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period last year, the firm posted $2.79 earnings per share. As a group, equities analysts anticipate that Thermo Fisher Scientific Inc. will post 12.14 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Oregon Public Employees Retirement Fund Buys 19,521,889 Shares of Thermo Fisher Scientific Inc. (TMO)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another publication, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be viewed at https://www.watchlistnews.com/oregon-public-employees-retirement-fund-buys-19521889-shares-of-thermo-fisher-scientific-inc-tmo/2832673.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Story: What is the Consumer Price Index (CPI)?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.